Search research articles
Contact Us
Filters
Showing results (1-10 of 44) with videos related to
Page
of 5
Sort By:
Pharmacoeconomics
|
July 17, 2022
The Cost Effectiveness of Axicabtagene Ciloleucel Versus Best Supportive Care in the Treatment of Adult Patients with Relapsed or Refractory Large B-Cell Lymphoma (LBCL) After Two or More Lines of Systemic Therapy in Canada
Christopher Hillis, Colin Vicente, Graeme Ball
Pharmacoeconomics - Open
|
February 22, 2018
Economic Evaluation of Bevacizumab for Treatment of Platinum-Resistant Recurrent Ovarian Cancer in Canada
Graeme Ball, Feng Xie, Jean-Eric Tarride
Journal of Medical Economics
|
September 16, 2025
Navigating the economic value of treatment sequencing in large B-cell lymphoma: insights into optimizing value and patient outcomes of CAR T-cell and other available therapies in Brazil
Samir Nabhan, Bradley Kievit, Rob Blissett, et al.
Current Oncology (Toronto, Ont.)
|
March 24, 2022
Cost-Effectiveness of Brexucabtagene Autoleucel versus Best Supportive Care for the Treatment of Relapsed/Refractory Mantle Cell Lymphoma following Treatment with a Bruton's Tyrosine Kinase Inhibitor in Canada
Graeme Ball, Christopher Lemieux, David Cameron, et al.
Nature
|
December 24, 2013
RecA bundles mediate homology pairing between distant sisters during DNA break repair
Christian Lesterlin, Graeme Ball, Lothar Schermelleh, et al.
Pharmacoeconomics - Open
|
April 24, 2021
Onwards and Upwards: A Systematic Survey of Economic Evaluation Methods in Oncology
Graeme Ball, Mitch Levine, Lehana Thabane, et al.
Mechanisms of Ageing and Development
|
December 18, 2019
Semi-automated quantitation of mitophagy in cells and tissues
Lambert Montava-Garriga, François Singh, Graeme Ball, et al.
Methods in Enzymology
|
January 24, 2012
A cell biologist's guide to high resolution imaging
Graeme Ball, Richard M Parton, Russell S Hamilton, et al.
Current Oncology (Toronto, Ont.)
|
October 27, 2022
Appraisals by Health Technology Assessment Agencies of Economic Evaluations Submitted as Part of Reimbursement Dossiers for Oncology Treatments: Evidence from Canada, the UK, and Australia
Graeme Ball, Mitchell A H Levine, Lehana Thabane, et al.
Current Oncology (Toronto, Ont.)
|
July 28, 2023
Health Technology Reassessment: Addressing Uncertainty in Economic Evaluations of Oncology Drugs at Time of Reimbursement Using Long-Term Clinical Trial Data
Graeme Ball, Mitchell A H Levine, Lehana Thabane, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 44) with videos related to
Sort By:
Page
of 5
Pharmacoeconomics
|
July 17, 2022
The Cost Effectiveness of Axicabtagene Ciloleucel Versus Best Supportive Care in the Treatment of Adult Patients with Relapsed or Refractory Large B-Cell Lymphoma (LBCL) After Two or More Lines of Systemic Therapy in Canada
Christopher Hillis, Colin Vicente, Graeme Ball
Pharmacoeconomics - Open
|
February 22, 2018
Economic Evaluation of Bevacizumab for Treatment of Platinum-Resistant Recurrent Ovarian Cancer in Canada
Graeme Ball, Feng Xie, Jean-Eric Tarride
Journal of Medical Economics
|
September 16, 2025
Navigating the economic value of treatment sequencing in large B-cell lymphoma: insights into optimizing value and patient outcomes of CAR T-cell and other available therapies in Brazil
Samir Nabhan, Bradley Kievit, Rob Blissett, et al.
Current Oncology (Toronto, Ont.)
|
March 24, 2022
Cost-Effectiveness of Brexucabtagene Autoleucel versus Best Supportive Care for the Treatment of Relapsed/Refractory Mantle Cell Lymphoma following Treatment with a Bruton's Tyrosine Kinase Inhibitor in Canada
Graeme Ball, Christopher Lemieux, David Cameron, et al.
Nature
|
December 24, 2013
RecA bundles mediate homology pairing between distant sisters during DNA break repair
Christian Lesterlin, Graeme Ball, Lothar Schermelleh, et al.
Pharmacoeconomics - Open
|
April 24, 2021
Onwards and Upwards: A Systematic Survey of Economic Evaluation Methods in Oncology
Graeme Ball, Mitch Levine, Lehana Thabane, et al.
Mechanisms of Ageing and Development
|
December 18, 2019
Semi-automated quantitation of mitophagy in cells and tissues
Lambert Montava-Garriga, François Singh, Graeme Ball, et al.
Methods in Enzymology
|
January 24, 2012
A cell biologist's guide to high resolution imaging
Graeme Ball, Richard M Parton, Russell S Hamilton, et al.
Current Oncology (Toronto, Ont.)
|
October 27, 2022
Appraisals by Health Technology Assessment Agencies of Economic Evaluations Submitted as Part of Reimbursement Dossiers for Oncology Treatments: Evidence from Canada, the UK, and Australia
Graeme Ball, Mitchell A H Levine, Lehana Thabane, et al.
Current Oncology (Toronto, Ont.)
|
July 28, 2023
Health Technology Reassessment: Addressing Uncertainty in Economic Evaluations of Oncology Drugs at Time of Reimbursement Using Long-Term Clinical Trial Data
Graeme Ball, Mitchell A H Levine, Lehana Thabane, et al.
Page
of 5